Intelligent Systems Software in Boca Raton, FL, announced Jan. 17 that the FDA had cleared its computer-aided detection (CAD) system, MammoReader. The product is designed to help
Intelligent Systems Software in Boca Raton, FL, announced Jan. 17 that the FDA had cleared its computer-aided detection (CAD) system, MammoReader. The product is designed to help in early detection of breast cancer by increasing the detection of subtle signs of cancer. The system is cleared for both screening and diagnostic use. Supporting the company's FDA application were clinical data from 327 cancer cases, which showed that breast cancer in 23% of the women diagnosed with the disease could have been discovered an average of 14 months earlier on screening mammograms, if MammoReader had been used, according to the company. MammoReader analyses are based on digitized mammograms. The systems, which will be marketed by Instrumentarium, will be priced at $99,500 and up.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.